Hilary D. Marston | |
Fields: | Global health, pandemic preparedness |
Workplaces: | Food and Drug Administration |
Alma Mater: | Yale College (BA) University of Pennsylvania (MD) Harvard University (MPH) [1] |
Hilary D. Marston is an American physician-scientist and global health policy advisor specializing in pandemic preparedness. She is the Chief Medical Officer of the Food and Drug Administration.
Marston worked for McKinsey & Company and at the Bill & Melinda Gates Foundation as a program officer and special assistant. She then studied internal medicine at Brigham and Women's Hospital.[2] In 2013, Marston joined National Institute of Allergy and Infectious Diseases (NIAID). She has experience in outbreak response, including Zika virus and Ebola.[3] Marston served as a medical officer and policy advisor for global health and pandemic preparedness at NIAID.[4] On April 15, 2020, Marston was the inaugural speaker at the NIH Intramural Research Program's new COVID-19 scientific interest group. Her presentation was titled "The Biomedical Research Response to COVID-19: A View from NIAID." In 2022, Marston joined the US Food and Drug Administration as Chief Medical Officer.[5] She succeeded Janet Woodcock.